Click for best price
Ankylosing Spondylitis Treatment Market Size, Share 2023
Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture. The prevalence of ankylosing spondylitis is seen in about 0.1% to 0.5% of the adult population worldwide. It can occur at any age irrespective of gender; however, higher prevalence has been observed among males between the ages of 15?30 years.
This report aims to provide a comprehensive presentation of the global market for Ankylosing Spondylitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ankylosing Spondylitis Treatment. This report contains market size and forecasts of Ankylosing Spondylitis Treatment in global, including the following market information:
Global Ankylosing Spondylitis Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Ankylosing Spondylitis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The ankylosing spondylitis treatment market is growing at a significant rate due to the increasing prevalence of ankylosing spondylitis and rising awareness about diagnostics and treatments for the disease. In addition, government initiatives and improving healthcare infrastructure are driving the market for ankylosing spondylitis treatment. However, factors such as the high cost of treatment and lack of skilled surgeons and physiotherapists restrain the market from growing.
We surveyed the Ankylosing Spondylitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ankylosing Spondylitis Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Ankylosing Spondylitis Treatment Market Segment Percentages, by Type, 2022 (%)
Disease-Modifying Anitrheumatic Drugs (DMARDs)
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Biologics
Global Ankylosing Spondylitis Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Ankylosing Spondylitis Treatment Market Segment Percentages, by Application, 2022 (%)
Juveniles
Adults
Global Ankylosing Spondylitis Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Ankylosing Spondylitis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ankylosing Spondylitis Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ankylosing Spondylitis Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Amgen
Janssen Biotech
Merck
UCB
Boehringer Ingelheim
Johnson & Johnson
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ankylosing Spondylitis Treatment, market overview.
Chapter 2: Global Ankylosing Spondylitis Treatment market size in revenue.
Chapter 3: Detailed analysis of Ankylosing Spondylitis Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ankylosing Spondylitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Ankylosing Spondylitis Treatment Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ankylosing Spondylitis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ankylosing Spondylitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ankylosing Spondylitis Treatment Overall Market Size
2.1 Global Ankylosing Spondylitis Treatment Market Size: 2022 VS 2029
2.2 Global Ankylosing Spondylitis Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ankylosing Spondylitis Treatment Players in Global Market
3.2 Top Global Ankylosing Spondylitis Treatment Companies Ranked by Revenue
3.3 Global Ankylosing Spondylitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Ankylosing Spondylitis Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Ankylosing Spondylitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ankylosing Spondylitis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Ankylosing Spondylitis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Ankylosing Spondylitis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ankylosing Spondylitis Treatment Market Size Markets, 2022 & 2029
4.1.2 Disease-Modifying Anitrheumatic Drugs (DMARDs)
4.1.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
4.1.4 Biologics
4.2 By Type - Global Ankylosing Spondylitis Treatment Revenue & Forecasts
4.2.1 By Type - Global Ankylosing Spondylitis Treatment Revenue, 2018-2023
4.2.2 By Type - Global Ankylosing Spondylitis Treatment Revenue, 2024-2029
4.2.3 By Type - Global Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ankylosing Spondylitis Treatment Market Size, 2022 & 2029
5.1.2 Juveniles
5.1.3 Adults
5.2 By Application - Global Ankylosing Spondylitis Treatment Revenue & Forecasts
5.2.1 By Application - Global Ankylosing Spondylitis Treatment Revenue, 2018-2023
5.2.2 By Application - Global Ankylosing Spondylitis Treatment Revenue, 2024-2029
5.2.3 By Application - Global Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Ankylosing Spondylitis Treatment Market Size, 2022 & 2029
6.2 By Region - Global Ankylosing Spondylitis Treatment Revenue & Forecasts
6.2.1 By Region - Global Ankylosing Spondylitis Treatment Revenue, 2018-2023
6.2.2 By Region - Global Ankylosing Spondylitis Treatment Revenue, 2024-2029
6.2.3 By Region - Global Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Ankylosing Spondylitis Treatment Revenue, 2018-2029
6.3.2 US Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.3.3 Canada Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.3.4 Mexico Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Ankylosing Spondylitis Treatment Revenue, 2018-2029
6.4.2 Germany Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.4.3 France Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.4.4 U.K. Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.4.5 Italy Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.4.6 Russia Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.4.8 Benelux Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Ankylosing Spondylitis Treatment Revenue, 2018-2029
6.5.2 China Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.5.3 Japan Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.5.4 South Korea Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.5.6 India Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Ankylosing Spondylitis Treatment Revenue, 2018-2029
6.6.2 Brazil Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.6.3 Argentina Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ankylosing Spondylitis Treatment Revenue, 2018-2029
6.7.2 Turkey Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.7.3 Israel Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Ankylosing Spondylitis Treatment Market Size, 2018-2029
6.7.5 UAE Ankylosing Spondylitis Treatment Market Size, 2018-2029
7 Ankylosing Spondylitis Treatment Companies Profiles
7.1 Abbvie
7.1.1 Abbvie Company Summary
7.1.2 Abbvie Business Overview
7.1.3 Abbvie Ankylosing Spondylitis Treatment Major Product Offerings
7.1.4 Abbvie Ankylosing Spondylitis Treatment Revenue in Global Market (2018-2023)
7.1.5 Abbvie Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Ankylosing Spondylitis Treatment Major Product Offerings
7.2.4 Amgen Ankylosing Spondylitis Treatment Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Janssen Biotech
7.3.1 Janssen Biotech Company Summary
7.3.2 Janssen Biotech Business Overview
7.3.3 Janssen Biotech Ankylosing Spondylitis Treatment Major Product Offerings
7.3.4 Janssen Biotech Ankylosing Spondylitis Treatment Revenue in Global Market (2018-2023)
7.3.5 Janssen Biotech Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Ankylosing Spondylitis Treatment Major Product Offerings
7.4.4 Merck Ankylosing Spondylitis Treatment Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 UCB
7.5.1 UCB Company Summary
7.5.2 UCB Business Overview
7.5.3 UCB Ankylosing Spondylitis Treatment Major Product Offerings
7.5.4 UCB Ankylosing Spondylitis Treatment Revenue in Global Market (2018-2023)
7.5.5 UCB Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Ankylosing Spondylitis Treatment Major Product Offerings
7.6.4 Boehringer Ingelheim Ankylosing Spondylitis Treatment Revenue in Global Market (2018-2023)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Ankylosing Spondylitis Treatment Major Product Offerings
7.7.4 Johnson & Johnson Ankylosing Spondylitis Treatment Revenue in Global Market (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ankylosing Spondylitis Treatment Market Opportunities & Trends in Global Market
Table 2. Ankylosing Spondylitis Treatment Market Drivers in Global Market
Table 3. Ankylosing Spondylitis Treatment Market Restraints in Global Market
Table 4. Key Players of Ankylosing Spondylitis Treatment in Global Market
Table 5. Top Ankylosing Spondylitis Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Ankylosing Spondylitis Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Ankylosing Spondylitis Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Ankylosing Spondylitis Treatment Product Type
Table 9. List of Global Tier 1 Ankylosing Spondylitis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ankylosing Spondylitis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Ankylosing Spondylitis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Ankylosing Spondylitis Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Ankylosing Spondylitis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Ankylosing Spondylitis Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Ankylosing Spondylitis Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Ankylosing Spondylitis Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Abbvie Company Summary
Table 31. Abbvie Ankylosing Spondylitis Treatment Product Offerings
Table 32. Abbvie Ankylosing Spondylitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Abbvie Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Ankylosing Spondylitis Treatment Product Offerings
Table 36. Amgen Ankylosing Spondylitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Key News & Latest Developments
Table 38. Janssen Biotech Company Summary
Table 39. Janssen Biotech Ankylosing Spondylitis Treatment Product Offerings
Table 40. Janssen Biotech Ankylosing Spondylitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Janssen Biotech Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Ankylosing Spondylitis Treatment Product Offerings
Table 44. Merck Ankylosing Spondylitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. UCB Company Summary
Table 47. UCB Ankylosing Spondylitis Treatment Product Offerings
Table 48. UCB Ankylosing Spondylitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. UCB Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim Ankylosing Spondylitis Treatment Product Offerings
Table 52. Boehringer Ingelheim Ankylosing Spondylitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Ankylosing Spondylitis Treatment Product Offerings
Table 56. Johnson & Johnson Ankylosing Spondylitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
List of Figures
Figure 1. Ankylosing Spondylitis Treatment Segment by Type in 2022
Figure 2. Ankylosing Spondylitis Treatment Segment by Application in 2022
Figure 3. Global Ankylosing Spondylitis Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ankylosing Spondylitis Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Ankylosing Spondylitis Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ankylosing Spondylitis Treatment Revenue in 2022
Figure 8. By Type - Global Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
Figure 16. US Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
Figure 28. China Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Ankylosing Spondylitis Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Ankylosing Spondylitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Abbvie Ankylosing Spondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Ankylosing Spondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Janssen Biotech Ankylosing Spondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Ankylosing Spondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. UCB Ankylosing Spondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Boehringer Ingelheim Ankylosing Spondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Johnson & Johnson Ankylosing Spondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
